ClinicalTrials.gg
RecruitingNCT06308380EREPSOLMUpdated May 11, 2025

Effectiveness of Rehabilitation Protocol in Patients With Shortened Posterior Leg Muscles

An interventional study of Specific protocol of rehabilitation exercise and Short gastrocnemius surgery. in Equinus Deformity of Foot, Gastrocnemius Equinus and Contracture, sponsored by Fundación Universidad Católica de Valencia San Vicente Mártir. Recruiting at 3 sites in Spain. Open to participants aged 20 Years to 90 Years. Per ClinicalTrials.gov, last updated 2025-05-11.

Sponsored by Fundación Universidad Católica de Valencia San Vicente Mártir · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Mar 2024; still recruiting 2 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
20 Years to 90 Years
Sex
All
01

Study summary

The goal of this clinical study is to develop a specialized rehabilitation exercise protocol designed for patients diagnosed with foot pathologies and calf muscle shortening, regardless of their choice to undergo minimally invasive ultrasound-guided surgery. The primary focus is to assess disparities in outcomes, particularly in the recovery of ankle mobility degrees. Additionally, for patients opting for minimally invasive ultrasound-guided surgery, the study aims to evaluate the resumption of both sporting activities and daily routines using the aforementioned specific rehabilitation protocol.

The primary questions this study aims to answer are:

  • How does the proposed rehabilitation protocol impact ankle mobility recovery for patients with foot pathologies and calf muscle shortening?
  • What are the differences observed in the return to sporting activities and daily life among patients undergoing minimally invasive ultrasound-guided surgery, following the prescribed protocol?

Participants enrolled in this study will be engaged in:

Undertaking the specified rehabilitation exercises tailored for foot pathologies and calf muscle shortening.

Those opting for minimally invasive ultrasound-guided surgery will follow the same rehabilitation protocol post-surgery to assess its impact on their return to normal activities.

If there exists a comparison group:

Researchers will compare participants who undergo minimally invasive ultrasound-guided surgery against those who choose other treatment options to discern any differential effects on ankle mobility recovery and resumption of activities.

Read the detailed description

Calf muscle tightness and limited ankle dorsiflexion range of motion are associated with various foot pathologies, including plantar fasciitis, Achilles tendinitis, and altered gait patterns. While conservative rehabilitation exercises are first-line treatment, minimally invasive ultrasound-guided gastrocnemius recession can be considered for refractory cases. However, no studies have compared using the same rehabilitation protocol post-surgery versus without surgery. The aim of this randomized controlled trial is to evaluate the efficacy of a specialized 12-week rehabilitation protocol on ankle dorsiflexion range of motion in patients with foot pathologies and calf tightness. Secondary objectives are to compare post-surgical outcomes in patients undergoing minimally invasive ultrasound-guided gastrocnemius recession followed by the 12-week rehabilitation protocol, versus patients only undergoing the rehabilitation protocol, in terms of ankle dorsiflexion range of motion, foot posture and plantar pressures, pain scores, function scores, and return to activities.

A parallel group design will be used, with participants assigned to two groups: Group A will undergo the rehabilitation protocol only and Group B will undergo the rehabilitation protocol after ultrasound-assisted gastrocnemius surgery. Adult patients between 20 and 90 years of age with clubfoot pathology and gastrocsoleus contracture with calf strain will be recruited. The target sample size is 40 patients, equally distributed in the two groups.

The study protocol will consist of assessing participants at baseline for calf muscle length, ankle dorsiflexion range of motion, foot posture, plantar pressures, pain and function. Group A will undergo the 12-week rehabilitation protocol. Group B will undergo ultrasound-guided minimally invasive surgery first, followed by the 12-week rehabilitation protocol. Evaluations will be performed at Pre-surgery, 2 months, 6 months.

Statistical analysis will compare the two groups on all outcome measures using appropriate statistical tests. Expected results are improved ankle dorsiflexion range of motion in both groups, with greater improvements in Group B post-surgery. This study will provide evidence on a targeted rehabilitation protocol for calf tightness, and also insight into the added benefits of minimally invasive surgery when combined with focused rehabilitation.

02

Conditions studied

  • Equinus Deformity of Foot
  • Gastrocnemius Equinus
  • Contracture

Keywords

  • foot deformity
  • calf shortening
  • foot and ankle disease
  • stretching and muscle strengthening
  • exercise post surgery
03

In context

Contracture

79 studies on the registry are indexed under Contracture; 18 are open to participants now.

This study's planned enrollment of 40 is above the median of 33 across 62 interventional studies indexed under Contracture.

Browse Contracture studies →

Lead sponsor

Fundación Universidad Católica de Valencia San Vicente Mártir is the lead sponsor of 25 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with shortened posterior musculature.
  • Chronic ankle pain.
  • Limitations in activities of daily living.
  • Atypical gait.
  • Clubfoot.

Exclusion criteria

Exclusion Criteria:

  • Previous MMII surgeries.
  • Neuropathic pain.
  • Bony cap equinus.
  • Analgesic physiotherapy.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    Rehabilitation only

    All patients who do not wish to undergo mini- invasive surgery to lengthen the calf muscles are part of the control group. They will be subjected to a specific protocol of rehabilitation exercise 3times a week for 12 weeks.

    Procedure: Specific protocol of rehabilitation exercise

  • Experimental
    Surgery

    All patients who wish to undergo mini invasive surgery to lengthen the calf muscles are part of the experimental group. they will be subjected to a specific protocol of rehabilitation exercise exercise 3times a day every day for 4weeks.

    Procedure: Specific protocol of rehabilitation exercise · Procedure: Short gastrocnemius surgery.

Interventions

  • ProcedureSpecific protocol of rehabilitation exercise

    Specific protocol of rehabilitation exercise

    Also known as: Exercise

  • ProcedureShort gastrocnemius surgery.

    During surgery, a partial release of the gastrocnemius muscle tendon is performed to relieve tension and allow greater range of motion. This procedure is typically performed on an outpatient basis and under local or regional anesthesia, which allows for a quicker recovery compared to more invasive surgeries.

06

What researchers measure

Primary outcomes

  1. Gait Analysis

    The Gait Analysis is an examination useful for studying patterns, aided by instruments that measure the load on each limb and overall ambulation. The gait cycle ia s particularly complex phenomenon, resulting from the coordination between the nervous system, musculoskeletal system, and sensory input. The patient is required to walk (at varying intervals) on a treadmill or directly on a platform. It's a non invasive examination.

    Time frame: Pre-surgery, 2 months, 6 months.

  2. Baropodometric examination

    The baropodometric examination, a pivotal tool in studying plantar pressure distribution, is conducted on the Zebris platform. This platform provides a detailed and precise analysis of pressures exerted on the plantar surface during walking, enabling a comprehensive assessment of alterations in load distribution on the feet. Zebris' technology allows for gathering relevant data on pressure points and load areas, facilitating the identification of abnormal gait patterns and postural imbalances. Integrated within the Zebris platform, this examination becomes an invaluable resource for comprehensive biomechanical assessment and personalized treatment planning for various foot pathologies.

    Time frame: Pre-surgery, 2 months, 6 months.

Secondary outcomes

  1. Passive ankle mobility

    It is a tool that measures muscle strength and is used to evaluate the Passive ankle mobility test. The latter allows us to evaluate the equine.Measurement in degrees.

    Time frame: Pre-surgery, 2 months, 6 months.

  2. Short Form Health Survey 36 score

    It's a self administered questionnaire filled out by the patient, aimed at quantifying health status and measuring health related quality of life. On this 0 - 100 scale of the The Short Form-36 Health Survey(SF-36), the higher the score obtained, the better the health status. Thus, 0 represents the worst state of health and 100 the best state of health as measured by the SF-36.

    Time frame: Pre-surgery, 2 months, 6 months.

  3. Foot Function Index

    It is a questionnaire consisting of 23 items designed to assess the impact that foot pathologies have on the patient's perceived health status in terms of pain, disability and activity limitation.

    Time frame: Pre-surgery, 2 months, 6 months.

  4. American Orthopedic Foot and Ankle Score

    The AOFAS Ankle-Hindfoot Scale was designed by the American Foot and Ankle Society to provide an international method to assess the clinical status of the ankle and foot. This questionnaire incorporates subjective and objective factors that are scored using a numerical scale and describe variables of function, alignment and pain. The score ranges from 0 to 100 depending on the degree of limitation of the patient.

    Time frame: Pre-surgery, 2 months, 6 months.

  5. Halasi score

    The Halasi Ankle Activity Score is a ten-point scoring system in which various sports and physical activities are divided into 10 groups according to the biomechanical load on the ankle; for each sport discipline, three levels can be selected ranging from recreational level (more than one hour per week) to professional or international elite level.

    Time frame: Pre-surgery, 2 months, 6 months.

Other outcomes

  1. Olerud and Molander ankle score.

    it is a functional assessment scale that uses a numerical scoring approach to measure a patient's function or status in relation to nine different items. In this case, the variable measured through this scale is a continuous quantitative variable. the scale assigns scores ranging from 0 to 100, based on the patient's responses or evaluations regarding the nine mentioned items. Higher scores indicate better functioning or a more favorable health status, while lower scores indicate impaired functioning or a less favorable health state.

    Time frame: Pre-surgery, 2 months, 6 months.

  2. Visual Analogue Scale

    A 10-centimeter horizontal line is used, with extreme expressions of a symptom at both ends; absence or lesser intensity on the left and greater intensity on the right. The patient marks the point indicating intensity, measures it with a millimeter ruler, and expresses it in centimeters. The classification is: Mild pain (less than 3), moderate pain (between 4 and 7), and severe pain (8 or higher).

    Time frame: Pre-surgery, 2 months, 6 months.

07

Study locations

3 of 3 sites recruiting
  • Podologia Avançada
    Granollers, Barcelona 08401, Spain
    Recruiting
    • Lluis Castillo-Sanchez, Dr · Contactinfo@podologiaavanzadabcn.com · 610143173
    • Lluis Castillo, Dr · Sub investigator
    • Cristina Razzano · Principal investigator
    • Simone Moroni · Sub investigator
  • Clinica Mayral foot center
    Barcelona, Barcelon 08029, Spain
    Recruiting
    • Jordi Mayral · Contactbarcelona@clinicamayral.com · (+34) 93 339 78 41
    • Jordi Mayral · Sub investigator
    • Cristina Razzano · Principal investigator
    • Simone Moroni · Sub investigator
  • Clinicas UCV
    Valencia, València 46001, Spain
    Recruiting
    • Pablo Vera-Ivars, Dr. · Contactclinicas.ucv@ucv.es · 963 92 06 24
    • Cristina Mico-Salcedo · Contactclinicas.ucv@ucv.es · 963 92 06 24
    • Javier Ferrer-Torregrosa, Dr · Principal investigator
    • Bianca Alina Achim Borza · Principal investigator
08

References and documents

Publications

  • Pearce CJ, Seow D, Lau BP. Correlation Between Gastrocnemius Tightness and Heel Pain Severity in Plantar Fasciitis. Foot Ankle Int. 2021 Jan;42(1):76-82. doi: 10.1177/1071100720955144. Epub 2020 Sep 13. PubMed 32924578 ↗
  • Nakale NT, Strydom A, Saragas NP, Ferrao PNF. Association Between Plantar Fasciitis and Isolated Gastrocnemius Tightness. Foot Ankle Int. 2018 Mar;39(3):271-277. doi: 10.1177/1071100717744175. Epub 2017 Dec 4. PubMed 29198141 ↗
  • Medeiros DM, Martini TF. Chronic effect of different types of stretching on ankle dorsiflexion range of motion: Systematic review and meta-analysis. Foot (Edinb). 2018 Mar;34:28-35. doi: 10.1016/j.foot.2017.09.006. Epub 2017 Oct 27. PubMed 29223884 ↗
  • Meyer DC, Werner CM, Wyss T, Vienne P. A mechanical equinometer to measure the range of motion of the ankle joint: interobserver and intraobserver reliability. Foot Ankle Int. 2006 Mar;27(3):202-5. doi: 10.1177/107110070602700309. PubMed 16539903 ↗
  • Barouk P, Barouk LS. Clinical diagnosis of gastrocnemius tightness. Foot Ankle Clin. 2014 Dec;19(4):659-67. doi: 10.1016/j.fcl.2014.08.004. Epub 2014 Sep 26. PubMed 25456715 ↗
  • Villanueva M, Iborra A, Rodriguez G, Sanz-Ruiz P. Ultrasound-guided gastrocnemius recession: a new ultra-minimally invasive surgical technique. BMC Musculoskelet Disord. 2016 Oct 3;17(1):409. doi: 10.1186/s12891-016-1265-7. PubMed 27716217 ↗
  • Moroni S, Fernandez-Gibello A, Nieves GC, Montes R, Zwierzina M, Vazquez T, Garcia-Escudero M, Duparc F, Moriggl B, Konschake M. Anatomical basis of a safe mini-invasive technique for lengthening of the anterior gastrocnemius aponeurosis. Surg Radiol Anat. 2021 Jan;43(1):53-61. doi: 10.1007/s00276-020-02536-1. Epub 2020 Jul 23. PubMed 32705404 ↗
  • Baraja-Vegas L, Martin-Rodriguez S, Piqueras-Sanchiz F, Faundez-Aguilera J, Bautista IJ, Barrios C, Garcia-Escudero M, Fernandez-de-Las-Penas C. Localization of Muscle Edema and Changes on Muscle Contractility After Dry Needling of Latent Trigger Points in the Gastrocnemius Muscle. Pain Med. 2019 Jul 1;20(7):1387-1394. doi: 10.1093/pm/pny306. Erratum In: Pain Med. 2020 Apr 1;21(4):880. doi: 10.1093/pm/pnz359. PubMed 30715456 ↗
  • Cobacho MT, Barcia JM, Freijo-Gutierrez V, Caballero-Gomez F, Ferrer-Torregrosa J. A Predictive Model for Gastrocnemius Tightness in Forefoot Pain and Intractable Plantar Keratosis of the Second Rocker. J Am Podiatr Med Assoc. 2021 May 1;111(3):Article_12. doi: 10.7547/18-024. PubMed 34144595 ↗
  • Head J, Mallows A, Debenham J, Travers MJ, Allen L. The efficacy of loading programmes for improving patient-reported outcomes in chronic midportion Achilles tendinopathy: A systematic review. Musculoskeletal Care. 2019 Dec;17(4):283-299. doi: 10.1002/msc.1428. Epub 2019 Nov 25. PubMed 31763774 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2024 to primary completion in Jul 2024, 3 months.

Of 30 interventional studies with no phase under Contracture, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 55. This study's 3 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 19, 2024
First posted
Mar 13, 2024
StartActual
Mar 10, 2024
Primary completionActual
Jul 1, 2024
CompletionEst.
Jun 10, 2025
Last update
May 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06308380
Lead sponsor
Fundación Universidad Católica de Valencia San Vicente Mártir
Responsible party
Sponsor
First posted
Mar 13, 2024
Start date
Mar 10, 2024
Primary completion
Jul 1, 2024
Completion
Jun 10, 2025 (estimated)
Last update
May 11, 2025

Study contacts

Cristina Razzano
Contact
cristina.razzano@mail.ucv.es
+34963637412
Maria del Mar Aranda, Dra.
Contact
mariamar.aranda@ucv.es
+34963637412
Javier Ferrer-Torregrosa, Dr.
study director · FundaciónUcv
Juan Vicente-Mampel, Dr.
study director · FundaciónUcv

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion